SUFU and central nervous system cancer: Results showed that glioma patients with high expression of Sufu had favorable prognosis in CGGA (except WHO II, P = 0.0612) (Figure 1A, P < 0.05), testified by the other two validation datasets (Figure 1B, 1C) and TCGA (Supplementary Figure 2).